These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

337 related items for PubMed ID: 26561205

  • 1. MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma.
    Wang LK, Pan SH, Chang YL, Hung PF, Kao SH, Wang WL, Lin CW, Yang SC, Liang CH, Wu CT, Hsiao TH, Hong TM, Yang PC.
    Oncotarget; 2016 Jan 05; 7(1):386-401. PubMed ID: 26561205
    [Abstract] [Full Text] [Related]

  • 2. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.
    Menezes ME, Shen XN, Das SK, Emdad L, Sarkar D, Fisher PB.
    Oncotarget; 2016 Dec 06; 7(49):80175-80189. PubMed ID: 27863394
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
    Chang TH, Tsai MF, Gow CH, Wu SG, Liu YN, Chang YL, Yu SL, Tsai HC, Lin SW, Chen YW, Kuo PY, Yang PC, Shih JY.
    Cancer Lett; 2017 Aug 28; 402():190-202. PubMed ID: 28610956
    [Abstract] [Full Text] [Related]

  • 4. Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma.
    Shih JY, Tsai MF, Chang TH, Chang YL, Yuan A, Yu CJ, Lin SB, Liou GY, Lee ML, Chen JJ, Hong TM, Yang SC, Su JL, Lee YC, Yang PC.
    Clin Cancer Res; 2005 Nov 15; 11(22):8070-8. PubMed ID: 16299238
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Osteopontin up-regulates critical epithelial-mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype.
    Li NY, Weber CE, Mi Z, Wai PY, Cuevas BD, Kuo PC.
    J Am Coll Surg; 2013 Jul 15; 217(1):17-26; discussion 26. PubMed ID: 23619316
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MDA-9/syntenin is essential for factor VIIa-induced signaling, migration, and metastasis in melanoma cells.
    Aissaoui H, Prévost C, Boucharaba A, Sanhadji K, Bordet JC, Négrier C, Boukerche H.
    J Biol Chem; 2015 Feb 06; 290(6):3333-48. PubMed ID: 25505176
    [Abstract] [Full Text] [Related]

  • 11. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W, Hao Z, Han JL, Zhu DJ, Jin ZF, Xie WL.
    Urol Oncol; 2014 Aug 06; 32(6):855-63. PubMed ID: 24968949
    [Abstract] [Full Text] [Related]

  • 12. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY, Lin TY, Hwang PA, Tseng LM, Chen RH, Tsao SM, Hsu J.
    Carcinogenesis; 2013 Apr 06; 34(4):874-84. PubMed ID: 23275155
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
    Kim B, Sohn EJ, Jung JH, Shin EA, You OH, Im J, Kim SH.
    Oncol Rep; 2014 Jan 06; 31(1):73-8. PubMed ID: 24145959
    [Abstract] [Full Text] [Related]

  • 14. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.
    Das SK, Guo C, Pradhan AK, Bhoopathi P, Talukdar S, Shen XN, Emdad L, Subler MA, Windle JJ, Sarkar D, Wang XY, Fisher PB.
    Oncotarget; 2016 Jul 26; 7(30):46848-46861. PubMed ID: 27341128
    [Abstract] [Full Text] [Related]

  • 15. HOXB13 and ALX4 induce SLUG expression for the promotion of EMT and cell invasion in ovarian cancer cells.
    Yuan H, Kajiyama H, Ito S, Chen D, Shibata K, Hamaguchi M, Kikkawa F, Senga T.
    Oncotarget; 2015 May 30; 6(15):13359-70. PubMed ID: 25944620
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.
    Kegelman TP, Wu B, Das SK, Talukdar S, Beckta JM, Hu B, Emdad L, Valerie K, Sarkar D, Furnari FB, Cavenee WK, Wei J, Purves A, De SK, Pellecchia M, Fisher PB.
    Proc Natl Acad Sci U S A; 2017 Jan 10; 114(2):370-375. PubMed ID: 28011764
    [Abstract] [Full Text] [Related]

  • 17. Mda-9/syntenin is expressed in uveal melanoma and correlates with metastatic progression.
    Gangemi R, Mirisola V, Barisione G, Fabbi M, Brizzolara A, Lanza F, Mosci C, Salvi S, Gualco M, Truini M, Angelini G, Boccardo S, Cilli M, Airoldi I, Queirolo P, Jager MJ, Daga A, Pfeffer U, Ferrini S.
    PLoS One; 2012 Jan 10; 7(1):e29989. PubMed ID: 22267972
    [Abstract] [Full Text] [Related]

  • 18. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.
    Chiou SH, Wang ML, Chou YT, Chen CJ, Hong CF, Hsieh WJ, Chang HT, Chen YS, Lin TW, Hsu HS, Wu CW.
    Cancer Res; 2010 Dec 15; 70(24):10433-44. PubMed ID: 21159654
    [Abstract] [Full Text] [Related]

  • 19. The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion.
    Das SK, Pradhan AK, Bhoopathi P, Talukdar S, Shen XN, Sarkar D, Emdad L, Fisher PB.
    Cancer Res; 2018 Jun 01; 78(11):2852-2863. PubMed ID: 29572229
    [Abstract] [Full Text] [Related]

  • 20. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression.
    Li Y, Zhao Z, Xu C, Zhou Z, Zhu Z, You T.
    Cancer Lett; 2014 Dec 01; 355(1):130-40. PubMed ID: 25218351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.